June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery: A case Series
Author Affiliations & Notes
  • leonardo ferlini
    San Camilo, Berazategui, Argentina
    centro de ojos quilmes, Quilmes, Argentina
  • Luciano Perrone
    San Camilo, Berazategui, Argentina
    centro de ojos quilmes, Quilmes, Argentina
  • Gaston Gomez Caride
    San Camilo, Berazategui, Argentina
    centro de ojos quilmes, Quilmes, Argentina
  • Mike Manotas
    centro de ojos quilmes, Quilmes, Argentina
  • Walter Biagini
    centro de ojos quilmes, Quilmes, Argentina
  • Ivan Saul
    centro de ojos quilmes, Quilmes, Argentina
  • gerardo valvecchia
    San Camilo, Berazategui, Argentina
    centro de ojos quilmes, Quilmes, Argentina
  • Footnotes
    Commercial Relationships leonardo ferlini, None; Luciano Perrone, None; Gaston Gomez Caride, None; Mike Manotas, None; Walter Biagini, None; Ivan Saul, None; gerardo valvecchia, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2985. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      leonardo ferlini, Luciano Perrone, Gaston Gomez Caride, Mike Manotas, Walter Biagini, Ivan Saul, gerardo valvecchia; Intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery: A case Series. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2985.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare endophtalmitits rates post routine cataract surgery with IOL implantation in patients with or without intracameral moxifloxacin 0.5% at the end of surgery

Methods: A retrospective study was conducted from January 2009 to November 2012 in San Camilo public eye center in Berazategui( Buenos Aires; Argentina) evaluating 6001 cataract surgeries performed by fellows . From 2009 to 2010 a total of 2941 eyes had routine cataract surgery with IOL implantation and no intracameral moxifloxacin at the end of surgery. From January 2011 to November 2012 a total of 3060 eyes had cataract surgery with IOL implantation and intracameral moxifloxacin 0.5% 0.1 ml whitout dilution at the end of surgery.

Results: Three cases of endophthalmitis ocurred in 6001 cataract surgeries. All cases were reported during the 2009-2010 period, and received the proper treatment. No cases were reported during the 2011-2012 period

Conclusions: No adverse effects were observed after intracameral injection of moxifloxacin 0.5% ophthalmic solution at the conclusion of routine cataract surgery. The overall rate of endophthalmitis was reduced from 0.1 % to 0%. It was found very effective for the prophylaxis of endophthalmitis at the conclusion of routine cataract surgery.

Keywords: 445 cataract • 513 endophthalmitis • 503 drug toxicity/drug effects  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×